Immune Regulation Based on the Targeting of Early Activation Molecules

Details for Australian Patent Application No. 2010241228 (hide)

Owner Albor Biologics, Inc.

Inventors Sanchez-Madrid, Francisco; Alonso, Carlos Martinez; Madrid, David Sancho; Rocamora, Pablo Engel; Artola, Enric Esplugues; Ramos, Javier Vega; Gomez, Pilar Lauzurica

Agent Cullens

Pub. Number AU-B-2010241228

Parent 2004209984

Filing date 4 November 2010

Wipo publication date 25 November 2010

Acceptance publication date 13 September 2012

International Classifications

C07K 16/28 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

A61P 37/00 Drugs for immunological or allergic disorders

C07K 14/705 Peptides having more than 20 amino acids

Event Publications

18 November 2010 Complete Application Filed

25 November 2010 Application Open to Public Inspection

  Published as AU-B-2010241228

13 September 2012 Application Accepted

  Published as AU-B-2010241228

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010241229-Separator apparatus and method

2010241227-Appliance Door